Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine for Prevention of Succinylcholine-Induced Bradycardia in Laparoscopy
NCT02676011Phase 2Completed
- Sponsor
- Assiut University
- Start
- Feb 2016
- Primary completion
- May 2016
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of atropine in bradycardia (4 arms), sponsored by Assiut University. Primary endpoint: Occurrence of bradycardia at 2 hours. Started Feb 2016; status: completed.
02
Drugs
atropine
03
Conditions
bradycardia
Beyond the preview
Go deeper on NCT02676011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02676011.